What have we learned from clinical trials in primary Sjögren's syndrome about pathogenesis?
Open Access
- 1 January 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 13 (1), 205
- https://doi.org/10.1186/ar3234
Abstract
In vitro and in vivo experimental data have pointed to new immunopathogenic mechanisms in primary Sjögren's syndrome (pSS). The availability of targeted treatment modalities has opened new ways to selectively target these mechanistic pathways in vivo. This has taught us that the role of proinflammatory cytokines, in particular TNFα, is not crucial in the immunopathogenesis of pSS. B cells appear to play a major role, as depletion of B cells leads to restoration of salivary flow and is efficacious for treatment of extraglandular manifestations and mucosa-associated lymphoid tissue lymphoma. B cells also orchestrate T-cell infiltration and ductal epithelial dearrangement in the salivary glands. Gene profiling of salivary gland tissue in relation to B-cell depletion confirms that the axis of IFNα, B-cell activating factor, B-cell activation, proliferation and survival constitutes a major pathogenic route in pSS.Keywords
This publication has 51 references indexed in Scilit:
- Activation of the type I interferon pathway in primary Sjogren’s syndromeJournal of Autoimmunity, 2010
- Tumor Necrosis Factor Inhibitors Block Apoptosis of Human Epithelial Cells of the Salivary GlandsAnnals of the New York Academy of Sciences, 2009
- Lack of efficacy of etanercept in Sjogren syndrome correlates with failed suppression of tumour necrosis factor and systemic immune activationAnnals Of The Rheumatic Diseases, 2008
- Augmented interferon‐α pathway activation in patients with Sjögren's syndrome treated with etanerceptArthritis & Rheumatism, 2007
- Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF productionAnnals Of The Rheumatic Diseases, 2007
- BAFF‐modulated repopulation of B lymphocytes in the blood and salivary glands of RITUXIMAB‐TREATED patients with Sjögren's syndromeArthritis & Rheumatism, 2007
- Progression of salivary gland dysfunction in patients with Sjogren's syndromeAnnals Of The Rheumatic Diseases, 2006
- Induction of interferon‐α by immune complexes or liposomes containing systemic lupus erythematosus autoantigen– and Sjögren's syndrome autoantigen–associated RNAArthritis & Rheumatism, 2006
- Immunopathogenesis of primary Sj??gren??s syndrome: implications for disease management and therapyCurrent Opinion in Rheumatology, 2005
- Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndromeThe Journal of Pathology, 2004